[HTML][HTML] Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance

X Hu, W Chen, F Li, P Ren, H Wu, C Zhang… - Frontiers in …, 2023 - frontiersin.org
Objective To explore the altered expression of estrogen receptor (ER), progesterone
receptor (PR), human epidermal growth factor receptor 2 (HER2), and cell proliferation index …

Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance.

X Hu, W Chen, F Li, P Ren, H Wu, C Zhang… - Frontiers in …, 2023 - europepmc.org
Objective To explore the altered expression of estrogen receptor (ER), progesterone
receptor (PR), human epidermal growth factor receptor 2 (HER2), and cell proliferation index …

Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance

X Hu, W Chen, F Li, P Ren, H Wu… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective To explore the altered expression of estrogen receptor (ER), progesterone
receptor (PR), human epidermal growth factor receptor 2 (HER2), and cell proliferation index …

[HTML][HTML] Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance

X Hu, W Chen, F Li, P Ren, H Wu, C Zhang… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Objective To explore the altered expression of estrogen receptor (ER), progesterone
receptor (PR), human epidermal growth factor receptor 2 (HER2), and cell proliferation index …

Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance.

X Hu, W Chen, F Li, P Ren, H Wu, C Zhang… - Frontiers in …, 2023 - europepmc.org
Objective To explore the altered expression of estrogen receptor (ER), progesterone
receptor (PR), human epidermal growth factor receptor 2 (HER2), and cell proliferation index …